Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).

@article{Esselstyn1999UpdatingA1,
  title={Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).},
  author={Caldwell B. Jr. Esselstyn},
  journal={The American journal of cardiology},
  year={1999},
  volume={84 3},
  pages={
          339-41, A8
        }
}
  • C. Esselstyn
  • Published 1 August 1999
  • Medicine
  • The American journal of cardiology

Tables from this paper

Defining an Overdue Requiem for Palliative Cardiovascular Medicine
  • C. Esselstyn
  • Medicine
    American journal of lifestyle medicine
  • 2016
TLDR
Despite overwhelming evidence for the safety, simplicity, and efficacy of plant nutrition to halt and prevent coronary artery disease, the cardiovascular medicine community has failed to embrace this option of therapy and persists in palliative treatments associated with high morbidity, mortality, and expense.
A way to reverse CAD?
TLDR
Most of the volunteer patients with CVD responded to intensive counseling, and those who sustained plant-based nutrition for a mean of 3.7 years experienced a low rate of subsequent cardiac events, suggesting this dietary approach to treatment deserves a wider test to see if adherence can be sustained in broader populations.
A way to reverse CAD? Though current medical and surgical treatments manage coronary artery disease, they do little to prevent or stop it. Nutritional intervention, as shown in our study and others, has halted and even reversed CAD.
TLDR
Most of the volunteer patients with CVD responded to intensive counseling, and those who sustained plant-based nutrition for a mean of 3.7 years experienced a low rate of subsequent cardiac events, which deserves a wider test to see if adherence can be sustained in broader populations.
Optimal Non-invasive Strategies to Reduce Recurrent Atherosclerotic Cardiovascular Disease Risk
TLDR
Combined approaches involving specific, tailored lifestyle, and pharmacological interventions will provide the most effective strategy for reducing the risk of recurrent CVD events.
The nutritional reversal of cardiovascular disease - Fact or fiction? Three case reports
TLDR
Three case histories of carotid, coronary, and peripheral vascular disease are reported to constitute an additional mandate that patients with cardiovascular disease be offered a plant-based option which is safe, inexpensive, empowering, and has the potential to end cardiovascular disease epidemic.
Is periodontal disease a risk factor for coronary artery disease (CAD)?
TLDR
Current evidence is insufficient to justify treatment of dental infections to arrest or reverse CAD or other systemic conditions (e.g., diabetes mellitus, stroke or adverse outcomes of pregnancies).
The Natural Cure of Coronary Heart Disease
TLDR
It is suggested that the increase in incidence in the last hundred years from virtually nil to epidemic proportions is due to lifestyle changes and that the disease can be reversed, with enormous potential savings for the National Health Service.
Angina rapidly improved with a plant-based diet and returned after resuming a Western diet
TLDR
The case of a 77-year-old woman with unstable angina, whose symptoms resolved without mechanical intervention while consuming a whole-food plant-based diet, highlights the potential of this lifestyle to help rapidly improve anginal symptoms and to contribute to improving the atherosclerotic disease process.
Outcomes of comprehensive lifestyle modification in inpatient setting.
Resolving the Coronary Artery Disease Epidemic Through Plant-Based Nutrition.
The world's advanced countries have easy access to plentiful high-fat food; ironically, it is this rich diet that produces atherosclerosis. In the world's poorer nations, many people subsist on a
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician's practice.
TLDR
A physician can influence patients in the decision to adopt a very low-fat diet that, combined with lipid-lowering drugs, can reduce cholesterol levels to below 150 mg/dL and uniformly result in the arrest or reversal of coronary artery disease.
Can we predict future acute coronary events in patients with stable coronary artery disease?
TLDR
Several standard risk factors for the development of coronary disease are recognized and a modulation of some of these risk factors has been shown to decrease the incidence and recurrence of coronary events.
Lipid lowering versus revascularization: an idea whose time (for testing) has come.
TLDR
It might be postulate that lipid lowering is the more effective therapy for both prevention of acute myocardial infarction and long-term survival.
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.
The Cholesterol-Lowering Atherosclerosis Study (CLAS) was a randomized, placebo-controlled, angiographic trial testing combined colestipol hydrochloride and niacin therapy in 162 nonsmoking men aged
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.
TLDR
It is found that in selected patients with multivessel disease suitable for treatment with either procedure, an initial strategy of PTCA does not result in a poorer five-year clinical outcome than CABG, although subsequent revascularization was required more often with this strategy.
Cholesterol reduction yields clinical benefit. A new look at old data.
TLDR
The results suggest that cholesterol lowering itself is beneficial but that specific adverse effects of fibrates and hormones increase the risk of CHD (hormones only), non-CHD, and total mortality.
Intensive lifestyle changes for reversal of coronary heart disease.
TLDR
More regression of coronary atherosclerosis occurred after 5 years than after 1 year in the experimental group, and in the control group, coronary Atherosclerosis continued to progress and more than twice as many cardiac events occurred.
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
TLDR
Lovastatin reduces the risk for the first acute major coronary event in men and women with average TC and LDL-C levels and below-average HDL- C levels and supports the inclusion of HDL-C in risk-factor assessment and the need for reassessment of the National Cholesterol Program guidelines.
Coronary-artery stents--gauging, gorging, and gouging.
  • E. Topol
  • Medicine
    The New England journal of medicine
  • 1998
Coronary stenting is now the predominant form of nonsurgical myocardial revascularization and accounts for well over 60 percent of the percutaneous coronary-revascularization procedures performed i...
...
1
2
3
...